Podcast Episodes

Episode 258: Curative radiotherapy for bladder cancer: Golden Ticket Winner #1

Season 2 Episode 258

Ananya Choudhury discussed the evidence for RT/TMT instead of surgery in muscle invasive bladder cancer. Regina Barragan-Carrillo (Golden Ticket Winn…

3 years, 2 months ago

View Episode

Episode 257: Chana Weinstock from the FDA

Season 2 Episode 257

Chana discusses her role at the FDA, how it functions and answers questions on topical issues.

3 years, 2 months ago

View Episode

Episode 256: ctDNA in urothelial studies.

Season 2 Episode 254

Mat Galski discusses the past, present and future of ctDNA in this disease.

3 years, 3 months ago

View Episode

Episode 255: How to get an academic paper accepted

Season 2 Episode 252

Walt Stadler gives tips to writing papers and navigating the review process.

3 years, 3 months ago

View Episode

Episode 254: New RCC studies at KCRS 2023 with Laurence Albiges

Season 2 Episode 255

Laurence Albiges discusses biomarker studies, new combinations and new therapies which were covered in the KCRS23 meeting in the ‘new studies' sessio…

3 years, 3 months ago

View Episode

Episode 253: Patients' perspectives on adjuvant and 1st line RCC

Rachel Giles (chair of IKCC) describes her data from patients on these topics in RCC

3 years, 3 months ago

View Episode

Episode 252: Talazoparib and its FDA approval in CRPC

Season 2 Episode 253

Neeraj Agarwal describes the TALAPRO-2 study and relevance of the HRR biomarker in the 2 cohorts presented. A discussion regarding other PARPis and B…

3 years, 4 months ago

View Episode

Episode 251: Final part of VEGF/TKI vs IPI/NIVO discussion

Season 2 Episode 251

Meredith Regan and David McDermott try to make sense of it all but are unexpectedly interrupted. PFS2 and TFS are covered along with previously discu…

3 years, 4 months ago

View Episode

Episode 250: Bob Motzer discusses IPI/Nivo vs VEGF/PD1

Season 2 Episode 249

After the discussion with Mike Atkins, Bob Motzer gives his perspective of the 1st line renal cancer situation .

3 years, 4 months ago

View Episode

Episode 249: ASCO 2023 emergency podcast IPI/NIVO vs VEGF/PD1 in kidney cancer

Prompted by a question during the oral kidney cancer session at ASCO, Mike Atkins explains his position. Disagreement prevails.

3 years, 4 months ago

View Episode